JERINI
DEAD

Serial Number

76272025

Owner

Jerini Bio Tools GmbH

Attorney

Matthew J. Smith

Filing Date

Jun 15, 2001

Add to watchlist:

No watchlists yet
View on USPTO

JERINI Trademark

Serial Number: 76272025 • Registration: 2894095

JERINI is a trademark filed by Jerini Bio Tools GmbH on June 15, 2001. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Jerini Bio Tools GmbH (2 trademarks)

Rudower Chaussee 29
Berlin 12489 , DE

Entity Type: 16

RUDOWER CHAUSSEE 29 12489

BERLIN FED. REP. , DD

Entity Type: 16

Trademark Details

Filing Date

June 15, 2001

Registration Date

October 19, 2004

Published for Opposition

July 27, 2004

Cancellation Date

May 20, 2011

Goods & Services

Chemical processing or transformation of inorganic or organic compounds for third parties, namely synthesis of peptides, polypeptides and proteins, manufacture of immobilized enzyme substrates, proteinmimetica and peptidimimetica, synthesis of peptides with sterically hindered amino acids, synthesis of peptides with distinct secondary structures and/or multiple antigenic peptides, immobilization of products and compounds, compound libraries, enzyme substrates, proteinmimetica and peptidomimetica, modification of peptides and proteins, and transformation of biologically active peptides and peptidomimetica

Scientific control apparatus and instruments, namely microscopes, ELISA readers, scanners, fluorescence readers, and phosphorimagers; scientific measuring and checking apparatus and instruments, comprising filters and membranes used in the field of biotechnology and pharmaceuticals; computer programs for synthesis of chemicals used in industry and science; computer programs for immobilization of chemicals used in industry and science; computer programs for analysis of patterns on surfaces, namely for analysis of filters and membranes; computer programs for the screening of compounds

Pharmaceutical and veterinary products, namely, preparations for sanitation, slimming, appetite suppressants, pharmaceuticals for acidosis therapeutics, analeptic and antihypoxaemics; analgesics and antirheumatic drugs, pharmaceuticals functioning as antihelmintics, antiallergics, antianemia drugs, antiarrhythmics, antibiotics and antiinfectives, antidementics, nootropics, antidiabetics, antidotes for the treatment of poisoning, antiemetics and antivertiginosics, antiepileptics, antihemorrhagics, antifibrinolytics, hemostatics, antihypertonics, antihypoglycemics, antihypotonics, anticoagulants, antimycotics, pharmaceuticals functioning as antiparasitics, antiphlogistics, antitussives, expectorants for use in atherosclerosis, balneotherapeutics and pharmaceuticals for thermal therapy, pharmaceuticals functioning as beta receptor blocking agents, pharmaceuticals for calcium channel blocking and inhibiting of the renin angiotensin-system, pharmaceuticals functioning as broncholytics, antiasthmetics cholagoguegics and for use in biliary tract therapeutics; pharmaceuticals functioning as cholinergics, corticoids, dermatics; all purpose disinfectants and antiseptics; pharmaceuticals functioning as dietetic agents and in alimentary therapeutics; diagnostic preparations functioning as diuretics, as agents for favoring blood flow, as withdrawal agents, as fibrinolytics, to treat gout, the flu and catarrhal fever; pharmaceuticals for the treatment of gynecological illnesses, namely, menstrual cramps, hemorrhoids, hepatitis; pharmaceuticals functioning as hypnotics and sedatives; pharmaceuticals to treat cardiac ailments; pharmaceuticals for use in caries and parodontosis; dental preparations, namely, dental abrasives; laxatives, pharmaceuticals functioning as antilipaemics, local anesthetics, neural therapeutics, gastrointestinal preparations, pharmaceuticals to treat migraines; pharmaceutical preparations for use in mouth and pharyngeal therapeutics; pharmaceuticals for use as muscle relaxants; pharmaceuticals for the treatment of addiction to narcotics; pharmaceuticals for use in neuropathology; ophthalmic pharmaceuticals for treating blindness, conjunctivitis, cataract, glaucoma, retinal detachment, stye, chalazion, dacryoadenitis, corneal clouding, keratitis, gasserian ganglionitis, vitreous opacity, amaurosis, retinopathy, central retinal artery occlusion, retinoblastoma, melanoma, optic neuritis, optic nerve atrophy; pharmaceuticals for use in osteoporosis and calcium metabolism modification; pharmaceuticals for the treatment of Parkinson's Disease and disturbances of the extrapyramidal system; pharmaceuticals for psychotropic, rhinologic and sinositic purposes; pharmaceuticals functioning as roborants and tonics; pharmaceuticals for use in thyroidal therapeutics; pharmaceuticals functioning as spasmolytics and inhibitors of thrombocyte aggregation; pharmaceuticals for the treatment of tuberculosis; pharmaceuticals functioning as alternants, urologics and venous agents; vitamins; pharmaceuticals for use as cytostatics and antineoplastic agents; homeopathic remedies, and medical plastics, namely sanitary preparations, veterinary preparations for use in the treatment of diseases of pets, livestock, wild animals, breeding animals and zoo animals; dietic supplements adapted for medical use, namely food for elderly people and for medically restricted diets; all-purpose disinfectants; preparations for destroying vermin; fungicides for domestic use; fungicides for agricultural use; herbicides for domestic use; herbicides for agricultural use; medicaments against artheriosclerosis; medicaments against restenosis; medicaments for tissue regeneration and tissue replacement; medicaments for cartilage regeneration; pharmaceutical and veterinary preparations for diabetes treatment; pharmaceutical and veterinary preparations for diabetes prophylaxis; medicaments against obesity; pharmaceutical and veterinary preparations for use in pets, livestock, wild animals, breeding animals and zoo animals against tumors; peptides for medical use; peptides for medical diagnostic use; peptidomimetics for medical use; peptiomimetics for medical diagnostic use; antibodies for medical use; antibodies for medical diagnostic use; DNA probes for medical use; DNA probes for medical diagnostic use; oligonucleotides for medical use; oligonucleotides for medical diagnostic use; small molecules for medical use

Chemicals used in industry and science, agriculture, horticulture and forestry, namely, proteins, peptides, peptidomimetics, small molecules, nucleic acids and polynucleotides; proteins and recombinant proteins for scientific research use; peptides for scientific research use; antibodies for scientific research use; DNA probes for scientific research use; oligonucleotides for scientific research use; antisense constructs for scientific research use; arrays of nucleic acids on a carrier material for scientific research use; arrays of proteins on a carrier material for scientific research use; arrays of peptides on a carrier material for scientific research use

Laboratory services of a chemist, biologist, biochemist, biotechnologists, gene technologists, molecular biologists, pharmacists, medical doctor, protein chemist; scientific and industrial research; computer programming

Filing History

CANCELLED SEC. 8 (6-YR)
May 20, 2011 C8..
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 3, 2010 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 3, 2010 REAP
REVIEW OF CORRESPONDENCE COMPLETE
Oct 24, 2007 CORV
PAPER RECEIVED
Oct 18, 2007 MAIL
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 11, 2004 TCCA
PAPER RECEIVED
Nov 9, 2004 MAIL
PAPER RECEIVED
Nov 8, 2004 MAIL
EXPARTE APPEAL TERMINATED
Oct 19, 2004 EXPT
REGISTERED-PRINCIPAL REGISTER
Oct 19, 2004 R.PR
PUBLISHED FOR OPPOSITION
Jul 27, 2004 PUBO
PAPER RECEIVED
Jul 19, 2004 MAIL
NOTICE OF PUBLICATION
Jul 7, 2004 NPUB
PAPER RECEIVED
Jun 18, 2004 MAIL
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 20, 2004 CNSA
Sec. 1(B) CLAIM DELETED
Apr 20, 2004 1.BD
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 20, 2004 CRFA
FAX SENT
Mar 5, 2004 FAXX
PAPER RECEIVED
Feb 25, 2004 MAIL
NON-FINAL ACTION MAILED
Feb 17, 2004 CNRT
CASE FILE IN TICRS
Jan 23, 2004 CFIT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jan 20, 2004 JURT
EX PARTE APPEAL-INSTITUTED
Jan 20, 2004 EXPI
EXPARTE APPEAL RECEIVED AT TTAB
Jan 12, 2004 EXAF
PAPER RECEIVED
Sep 11, 2003 MAIL
FINAL REFUSAL MAILED
Mar 12, 2003 CNFR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 3, 2003 CRFA
PAPER RECEIVED
Feb 3, 2003 MAIL
INQUIRY AS TO SUSPENSION MAILED
Jan 15, 2003 CNSI
LETTER OF SUSPENSION MAILED
Jun 18, 2002 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 12, 2002 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 11, 2002 CRFA
PAPER RECEIVED
Mar 11, 2002 MAIL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 1, 2002 CRFA
PAPER RECEIVED
Mar 1, 2002 MAIL
NON-FINAL ACTION MAILED
Aug 27, 2001 CNRT
ASSIGNED TO EXAMINER
Aug 20, 2001 DOCK